25 XP   0   0   10

Kamada
Buy, Hold or Sell?

Let's analyse Kamada together

PenkeI guess you are interested in Kamada. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Kamada. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Kamada

I send you an email if I find something interesting about Kamada.

Quick analysis of Kamada (30 sec.)










What can you expect buying and holding a share of Kamada? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$4.21
Expected worth in 1 year
$5.38
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
$1.17
Return On Investment
23.0%

For what price can you sell your share?

Current Price per Share
$5.09
Expected price per share
$4.6 - $5.95
How sure are you?
50%

1. Valuation of Kamada (5 min.)




Live pricePrice per Share (EOD)

$5.09

Intrinsic Value Per Share

$-6.63 - $0.17

Total Value Per Share

$-2.42 - $4.38

2. Growth of Kamada (5 min.)




Is Kamada growing?

Current yearPrevious yearGrowGrow %
How rich?$242m$173.5m$34.4m16.6%

How much money is Kamada making?

Current yearPrevious yearGrowGrow %
Making money$2m-$1.7m$3.8m185.4%
Net Profit Margin5.2%-6.9%--

How much money comes from the company's main activities?

3. Financial Health of Kamada (5 min.)




What can you expect buying and holding a share of Kamada? (5 min.)

Welcome investor! Kamada's management wants to use your money to grow the business. In return you get a share of Kamada.

What can you expect buying and holding a share of Kamada?

First you should know what it really means to hold a share of Kamada. And how you can make/lose money.

Speculation

The Price per Share of Kamada is $5.09. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Kamada.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Kamada, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.21. Based on the TTM, the Book Value Change Per Share is $0.29 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Kamada.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.091.7%0.040.9%-0.01-0.2%0.040.8%0.010.1%
Usd Book Value Change Per Share0.061.2%0.295.7%-0.01-0.2%0.112.2%0.071.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.061.2%0.295.7%-0.01-0.2%0.112.2%0.071.3%
Usd Price Per Share6.12-5.35-4.64-5.77-5.56-
Price to Earnings Ratio17.39-11,145.44-23.39-2,243.61-1,119.22-
Price-to-Total Gains Ratio97.41-86.12-26.36-48.86-11.94-
Price to Book Ratio1.45-1.50-1.54-1.99-2.94-
Price-to-Total Gains Ratio97.41-86.12-26.36-48.86-11.94-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.09
Number of shares196
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.290.11
Usd Total Gains Per Share0.290.11
Gains per Quarter (196 shares)57.2822.10
Gains per Year (196 shares)229.1288.40
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1022921908878
204584480177166
306876770265254
409169060354342
50114611350442430
60137513640530518
70160415930619606
80183318220707694
90206220510796782
100229122800884870

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%8.04.00.066.7%16.04.00.080.0%25.015.00.062.5%32.017.00.065.3%
Book Value Change Per Share3.00.01.075.0%7.04.01.058.3%15.04.01.075.0%24.015.01.060.0%29.017.03.059.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.049.00.0%
Total Gains per Share3.00.01.075.0%7.04.01.058.3%15.04.01.075.0%24.015.01.060.0%29.017.03.059.2%

Fundamentals of Kamada

About Kamada

Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its commercial products include KAMRAB/KEDRAB for treating prophylaxis of rabies; CYTOGAM for Prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM for prophylaxis of hemolytic disease of newborns; KAMRHO (D) IV for immune thermobocytopunic purpura; and Echis coloratus and Vipera palaestinae Antiserum for the treatment of snake bite. The company also distributes imported drug products in Israel, including BRAMITOB to manage chronic pulmonary infection; FOSTER to treat asthma; TRIMBOW for chronic obstructive pulmonary disease; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; AEROBIKA, an OPEP device; RUPAFIN and RUPAFIN ORAL SOLUTION for allergic rhinitis and Urticaria; SINTREDIUS for rheumatoid arthritis, systemic lupus erythematosus, and mild-moderate juvenile dermatomyositis; IVIG for immunodeficiency-related conditions; VARITECT for chicken pox and zoster herpes; ZUTECTRA and HEPATECT CP for hepatitis B; MEGALOTECT CP for CMV virus; RUCONEST for angioedema attack; HEPARIN SODIUM INJECTION for thrombo-embolic disorders and prophylaxis of deep vein thrombosis and thromboembolic events; ALBUMIN and ALBUMIN for blood plasma; Factor VIII for hemophilia type A; and Factor IX for hemophilia type B. In addition, it distributes COAGADEX for hereditary factor X deficiency; IXIARO for Japanese encephalitis; VIVOTIF for Salmonella Typhi; PROCYSBI for nephropathic cystinosis; LAMZEDE for alpha-mannosidosis; ELIGARD for prostate cancer; and BEVACIZUMAB KAMADA for various cancers. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.

Fundamental data was last updated by Penke on 2024-04-09 08:36:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Kamada.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Kamada earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Kamada to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 13.2% means that $0.13 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Kamada:

  • The MRQ is 13.2%. The company is making a huge profit. +2
  • The TTM is 5.2%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ13.2%TTM5.2%+8.0%
TTM5.2%YOY-6.9%+12.0%
TTM5.2%5Y5.4%-0.3%
5Y5.4%10Y-0.1%+5.6%
1.1.2. Return on Assets

Shows how efficient Kamada is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Kamada to the Drug Manufacturers - Specialty & Generic industry mean.
  • 1.4% Return on Assets means that Kamada generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Kamada:

  • The MRQ is 1.4%. Using its assets, the company is less efficient in making profit.
  • The TTM is 0.6%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.4%TTM0.6%+0.8%
TTM0.6%YOY-0.6%+1.2%
TTM0.6%5Y1.1%-0.5%
5Y1.1%10Y0.6%+0.5%
1.1.3. Return on Equity

Shows how efficient Kamada is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Kamada to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.1% Return on Equity means Kamada generated $0.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Kamada:

  • The MRQ is 2.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 0.9%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.1%TTM0.9%+1.2%
TTM0.9%YOY-1.0%+1.9%
TTM0.9%5Y1.3%-0.4%
5Y1.3%10Y0.5%+0.7%

1.2. Operating Efficiency of Kamada.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Kamada is operating .

  • Measures how much profit Kamada makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Kamada to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 7.6% means the company generated $0.08  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Kamada:

  • The MRQ is 7.6%. The company is operating less efficient.
  • The TTM is 4.4%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ7.6%TTM4.4%+3.3%
TTM4.4%YOY-4.8%+9.1%
TTM4.4%5Y6.7%-2.4%
5Y6.7%10Y1.4%+5.4%
1.2.2. Operating Ratio

Measures how efficient Kamada is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.92 means that the operating costs are $0.92 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Kamada:

  • The MRQ is 0.924. The company is less efficient in keeping operating costs low.
  • The TTM is 0.932. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.924TTM0.932-0.008
TTM0.932YOY1.000-0.068
TTM0.9325Y0.922+0.010
5Y0.92210Y0.985-0.063

1.3. Liquidity of Kamada.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Kamada is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.43 means the company has $3.43 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Kamada:

  • The MRQ is 3.427. The company is very able to pay all its short-term debts. +2
  • The TTM is 2.851. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ3.427TTM2.851+0.576
TTM2.851YOY2.247+0.603
TTM2.8515Y4.595-1.744
5Y4.59510Y4.018+0.577
1.3.2. Quick Ratio

Measures if Kamada is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Kamada to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.55 means the company can pay off $1.55 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Kamada:

  • The MRQ is 1.554. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.184. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.554TTM1.184+0.370
TTM1.184YOY1.235-0.051
TTM1.1845Y3.924-2.740
5Y3.92410Y3.690+0.234

1.4. Solvency of Kamada.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Kamada assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Kamada to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.31 means that Kamada assets are financed with 31.2% credit (debt) and the remaining percentage (100% - 31.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Kamada:

  • The MRQ is 0.312. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.373. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.312TTM0.373-0.060
TTM0.373YOY0.442-0.069
TTM0.3735Y0.279+0.094
5Y0.27910Y0.289-0.010
1.4.2. Debt to Equity Ratio

Measures if Kamada is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Kamada to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 45.4% means that company has $0.45 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Kamada:

  • The MRQ is 0.454. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.615. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.454TTM0.615-0.160
TTM0.615YOY0.792-0.177
TTM0.6155Y0.435+0.180
5Y0.43510Y0.435+0.000

2. Market Valuation of Kamada

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Kamada generates.

  • Above 15 is considered overpriced but always compare Kamada to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 17.39 means the investor is paying $17.39 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Kamada:

  • The EOD is 14.461. Based on the earnings, the company is underpriced. +1
  • The MRQ is 17.387. Based on the earnings, the company is fair priced.
  • The TTM is 11,145.435. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD14.461MRQ17.387-2.926
MRQ17.387TTM11,145.435-11,128.048
TTM11,145.435YOY23.388+11,122.047
TTM11,145.4355Y2,243.614+8,901.821
5Y2,243.61410Y1,119.225+1,124.390
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Kamada:

  • The EOD is 30.408. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 36.561. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 5.803. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD30.408MRQ36.561-6.153
MRQ36.561TTM5.803+30.758
TTM5.803YOY6.141-0.338
TTM5.8035Y2.629+3.174
5Y2.62910Y-134.799+137.428
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Kamada is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Kamada:

  • The EOD is 1.209. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.454. Based on the equity, the company is underpriced. +1
  • The TTM is 1.496. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.209MRQ1.454-0.245
MRQ1.454TTM1.496-0.042
TTM1.496YOY1.536-0.040
TTM1.4965Y1.986-0.490
5Y1.98610Y2.937-0.951
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Kamada.

3.1. Institutions holding Kamada

Institutions are holding 49.407% of the shares of Kamada.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-06-30State of Tennessee, Treasury Department000-8871-100
Total 000-8871-100

3.2. Funds holding Kamada

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Intl Stock Index Inv0.92370.0008530920380807.7266
2024-02-29Vanguard Developed Markets Index Admiral0.54350.001131239300
2024-02-29Vanguard Instl Ttl Intl Stk Mkt Idx TrII0.4030.000823166800
2023-12-31Forest Sea Eagle IL0.30360.508517449500
2024-02-29DFA International Small Company I0.30260.0096173913-15-0.0086
2023-12-31Forest 80/20 IL0.28510.353516386700
2023-12-31Analyst Small Cap Equity IL0.26323.26731512963224627.0861
2024-02-29Vanguard FTSE All-Wld ex-US SmCp Idx Ins0.2550.008714658500
2023-12-31Altshuler Shaham Equity Storm IL0.21850.4039125573-52062-29.3084
2023-12-31Forest 90/10 IL0.16320.1479380900
2023-12-31MORE Yeter IL0.15141.752587002-2000-2.2471
2023-12-31Dolphin 90/10 IL0.13840.1419795442760453.1459
2024-03-29Schwab International Small-Cap Eq ETF™0.13060.01047506500
2023-12-31Forest Bonds IL!0.12940.15257439100
2024-02-29DFA International Core Equity I0.12630.00157258635475.1377
2023-12-31Forest Equity IL0.12251.63057039400
2023-12-31MTF TR TA-SME60 IL0.12163.03626989135495103.1951
2023-12-31Meitav Stocks IL0.09390.91154000-15320-22.1004
2023-12-31Barometer Equity IL0.08680.78714988200
2023-12-31Acadian Non-US Small-Cap Developed Eqty0.07450.011642795-3579-7.7177
Total 4.836813.13642780069+63996+2.3%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Kamada compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0630.292-79%-0.009+114%0.113-44%0.066-5%
Book Value Per Share--4.2103.618+16%3.019+39%2.998+40%2.195+92%
Current Ratio--3.4272.851+20%2.247+52%4.595-25%4.018-15%
Debt To Asset Ratio--0.3120.373-16%0.442-29%0.279+12%0.289+8%
Debt To Equity Ratio--0.4540.615-26%0.792-43%0.435+4%0.435+5%
Dividend Per Share----0%-0%-0%-0%
Eps--0.0880.044+100%-0.010+111%0.039+125%0.007+1143%
Free Cash Flow Per Share--0.042-0.007+117%0.066-36%0.035+21%0.008+407%
Free Cash Flow To Equity Per Share--0.0510.093-46%0.025+104%0.082-38%0.029+73%
Gross Profit Margin--1.4700.828+78%0.220+569%0.700+110%0.977+50%
Intrinsic Value_10Y_max--0.171--------
Intrinsic Value_10Y_min---6.626--------
Intrinsic Value_1Y_max--0.031--------
Intrinsic Value_1Y_min---0.109--------
Intrinsic Value_3Y_max--0.082--------
Intrinsic Value_3Y_min---0.810--------
Intrinsic Value_5Y_max--0.121--------
Intrinsic Value_5Y_min---2.035--------
Market Cap292570655.000-20%351774711.360307227970.340+14%266561181.250+32%331829162.068+6%319848130.804+10%
Net Profit Margin--0.1320.052+156%-0.069+152%0.054+142%-0.001+101%
Operating Margin--0.0760.044+75%-0.048+162%0.067+13%0.014+446%
Operating Ratio--0.9240.932-1%1.000-8%0.922+0%0.985-6%
Pb Ratio1.209-20%1.4541.496-3%1.536-5%1.986-27%2.937-51%
Pe Ratio14.461-20%17.38711145.435-100%23.388-26%2243.614-99%1119.225-98%
Price Per Share5.090-20%6.1205.345+14%4.638+32%5.773+6%5.565+10%
Price To Free Cash Flow Ratio30.408-20%36.5615.803+530%6.141+495%2.629+1290%-134.799+469%
Price To Total Gains Ratio81.015-20%97.40886.119+13%26.357+270%48.857+99%11.945+716%
Quick Ratio--1.5541.184+31%1.235+26%3.924-60%3.690-58%
Return On Assets--0.0140.006+140%-0.006+140%0.011+28%0.006+143%
Return On Equity--0.0210.009+144%-0.010+149%0.013+63%0.005+285%
Total Gains Per Share--0.0630.292-79%-0.009+114%0.113-44%0.066-5%
Usd Book Value--242001451.000207987862.750+16%173520750.000+39%172295672.550+40%126151736.275+92%
Usd Book Value Change Per Share--0.0630.292-79%-0.009+114%0.113-44%0.066-5%
Usd Book Value Per Share--4.2103.618+16%3.019+39%2.998+40%2.195+92%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0880.044+100%-0.010+111%0.039+125%0.007+1143%
Usd Free Cash Flow--2405396.000-400151.000+117%3767250.000-36%1990369.800+21%474409.900+407%
Usd Free Cash Flow Per Share--0.042-0.007+117%0.066-36%0.035+21%0.008+407%
Usd Free Cash Flow To Equity Per Share--0.0510.093-46%0.025+104%0.082-38%0.029+73%
Usd Market Cap292570655.000-20%351774711.360307227970.340+14%266561181.250+32%331829162.068+6%319848130.804+10%
Usd Price Per Share5.090-20%6.1205.345+14%4.638+32%5.773+6%5.565+10%
Usd Profit--5058000.0002071000.000+144%-1768500.000+135%1918550.000+164%1084825.000+366%
Usd Revenue--38350244.00036109311.000+6%28652500.000+34%31156112.200+23%26898706.100+43%
Usd Total Gains Per Share--0.0630.292-79%-0.009+114%0.113-44%0.066-5%
 EOD+4 -4MRQTTM+26 -8YOY+29 -55Y+21 -1310Y+24 -10

4.2. Fundamental Score

Let's check the fundamental score of Kamada based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1514.461
Price to Book Ratio (EOD)Between0-11.209
Net Profit Margin (MRQ)Greater than00.132
Operating Margin (MRQ)Greater than00.076
Quick Ratio (MRQ)Greater than11.554
Current Ratio (MRQ)Greater than13.427
Debt to Asset Ratio (MRQ)Less than10.312
Debt to Equity Ratio (MRQ)Less than10.454
Return on Equity (MRQ)Greater than0.150.021
Return on Assets (MRQ)Greater than0.050.014
Total7/10 (70.0%)

4.3. Technical Score

Let's check the technical score of Kamada based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.426
Ma 20Greater thanMa 505.303
Ma 50Greater thanMa 1005.728
Ma 100Greater thanMa 2005.748
OpenGreater thanClose5.120
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Selling and Marketing Expenses  3,92203,922183,940-2293,711-6,088-2,377
Interest Expense  5000500-61439-35404-449-45
Tax Provision  211138093-2073-107-34
Income Tax Expense  130138093-2073-109-36



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets351,970
Total Liabilities109,968
Total Stockholder Equity242,001
 As reported
Total Liabilities 109,968
Total Stockholder Equity+ 242,001
Total Assets = 351,970

Assets

Total Assets351,970
Total Current Assets168,555
Long-term Assets183,414
Total Current Assets
Cash And Cash Equivalents 55,181
Net Receivables 21,260
Inventory 87,747
Other Current Assets 4,369
Total Current Assets  (as reported)168,555
Total Current Assets  (calculated)168,555
+/- 0
Long-term Assets
Property Plant Equipment 35,687
Goodwill 30,062
Intangible Assets 109,643
Long-term Assets Other 506
Long-term Assets  (as reported)183,414
Long-term Assets  (calculated)175,898
+/- 7,516

Liabilities & Shareholders' Equity

Total Current Liabilities49,183
Long-term Liabilities60,786
Total Stockholder Equity242,001
Total Current Liabilities
Short-term Debt 1,373
Accounts payable 24,599
Other Current Liabilities 23,065
Total Current Liabilities  (as reported)49,183
Total Current Liabilities  (calculated)49,036
+/- 147
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt7,449
Long-term Liabilities Other 53,234
Long-term Liabilities  (as reported)60,786
Long-term Liabilities  (calculated)60,683
+/- 102
Total Stockholder Equity
Common Stock14,897
Retained Earnings -39,867
Accumulated Other Comprehensive Income 3,324
Other Stockholders Equity 263,648
Total Stockholder Equity (as reported)242,001
Total Stockholder Equity (calculated)242,001
+/-0
Other
Capital Stock15,021
Cash and Short Term Investments 55,181
Common Stock Shares Outstanding 57,480
Current Deferred Revenue147
Liabilities and Stockholders Equity 351,970
Net Debt -46,432
Net Invested Capital 244,021
Net Working Capital 120,369
Property Plant and Equipment Gross 96,395
Short Long Term Debt Total 8,749



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-31
> Total Assets 
85,114
82,724
0
0
89,114
88,600
140,547
139,328
139,379
138,261
130,899
126,236
119,100
119,619
110,760
108,430
101,992
106,641
98,572
94,598
99,696
93,126
100,196
111,989
122,110
120,531
123,693
115,121
138,116
145,095
156,489
156,501
173,797
196,793
206,091
206,345
210,665
210,528
216,350
216,527
318,667
303,096
304,135
319,637
316,795
316,795
314,389
337,056
351,970
351,970337,056314,389316,795316,795319,637304,135303,096318,667216,527216,350210,528210,665206,345206,091196,793173,797156,501156,489145,095138,116115,121123,693120,531122,110111,989100,19693,12699,69694,59898,572106,641101,992108,430110,760119,619119,100126,236130,899138,261139,379139,328140,54788,60089,1140082,72485,114
   > Total Current Assets 
0
65,142
0
0
69,830
68,800
120,196
118,035
117,686
116,615
109,071
104,313
97,200
97,671
89,095
87,030
80,594
85,095
77,361
73,807
77,077
70,099
75,867
87,949
96,883
95,233
98,604
90,539
110,890
114,197
126,247
126,581
143,562
166,201
175,120
174,511
177,914
175,087
179,347
178,943
130,044
116,163
118,601
135,162
131,403
131,403
129,683
153,153
168,555
168,555153,153129,683131,403131,403135,162118,601116,163130,044178,943179,347175,087177,914174,511175,120166,201143,562126,581126,247114,197110,89090,53998,60495,23396,88387,94975,86770,09977,07773,80777,36185,09580,59487,03089,09597,67197,200104,313109,071116,615117,686118,035120,19668,80069,8300065,1420
       Cash And Cash Equivalents 
24,374
13,789
0
0
16,866
22,600
73,403
71,232
59,110
33,314
25,083
18,071
14,500
14,546
6,807
5,787
5,047
11,605
7,136
6,476
9,968
10,778
11,024
12,156
12,681
17,497
12,356
12,871
18,093
22,037
23,835
27,449
42,662
49,288
57,399
52,487
70,197
61,436
68,416
99,840
18,587
21,967
29,933
31,252
27,121
27,121
21,788
52,603
55,181
55,18152,60321,78827,12127,12131,25229,93321,96718,58799,84068,41661,43670,19752,48757,39949,28842,66227,44923,83522,03718,09312,87112,35617,49712,68112,15611,02410,7789,9686,4767,13611,6055,0475,7876,80714,54614,50018,07125,08333,31459,11071,23273,40322,60016,8660013,78924,374
       Short-term Investments 
18,312
21,610
0
0
16,929
10,400
9,152
4,707
15,067
38,811
42,603
42,207
37,400
37,350
37,511
36,473
23,259
23,921
22,391
20,722
18,664
17,865
15,906
27,986
30,338
30,451
32,233
32,051
32,499
33,800
38,122
39,380
31,245
47,124
47,272
47,230
39,069
48,038
36,137
0
0
0
0
0
68,516
0
0
0
0
000068,5160000036,13748,03839,06947,23047,27247,12431,24539,38038,12233,80032,49932,05132,23330,45130,33827,98615,90617,86518,66420,72222,39123,92123,25936,47337,51137,35037,40042,20742,60338,81115,0674,7079,15210,40016,9290021,61018,312
       Net Receivables 
0
13,725
0
0
14,257
12,000
13,740
19,817
21,576
15,876
17,514
18,486
19,900
20,352
19,992
17,959
25,952
17,964
19,411
18,523
22,851
13,779
24,865
24,663
32,794
19,110
26,642
16,683
30,982
26,652
28,789
25,721
26,482
28,002
22,803
32,176
26,632
24,458
30,193
30,940
44,034
29,435
24,148
30,881
24,528
20,925
27,658
26,755
21,260
21,26026,75527,65820,92524,52830,88124,14829,43544,03430,94030,19324,45826,63232,17622,80328,00226,48225,72128,78926,65230,98216,68326,64219,11032,79424,66324,86513,77922,85118,52319,41117,96425,95217,95919,99220,35219,90018,48617,51415,87621,57619,81713,74012,00014,2570013,7250
       Other Current Assets 
804
0
0
0
1,056
100
1,400
2,532
1,376
3,284
2,299
2,078
1,149
1,149
4,408
-100
909
5,922
100
4,022
1,057
-100
2,087
-100
822
-100
1,863
-100
1,086
0
0
0
1,255
0
0
0
2,553
0
0
0
4,065
0
6,410
6,884
3,875
0
3,077
0
4,369
4,36903,07703,8756,8846,41004,0650002,5530001,2550001,086-1001,863-100822-1002,087-1001,0574,0221005,922909-1004,4081,1491,1492,0782,2993,2841,3762,5321,4001001,056000804
   > Long-term Assets 
0
0
0
0
19,284
19,800
20,351
21,293
21,693
21,646
21,828
21,923
0
21,948
21,665
21,400
21,398
21,546
21,211
20,791
22,619
23,027
24,329
24,040
25,227
25,298
25,089
24,582
27,226
30,898
30,242
29,920
30,235
30,592
30,971
31,834
32,751
35,441
37,003
37,584
188,623
186,933
185,534
184,475
185,392
185,392
184,706
183,903
183,414
183,414183,903184,706185,392185,392184,475185,534186,933188,62337,58437,00335,44132,75131,83430,97130,59230,23529,92030,24230,89827,22624,58225,08925,29825,22724,04024,32923,02722,61920,79121,21121,54621,39821,40021,66521,948021,92321,82821,64621,69321,29320,35119,80019,2840000
       Property Plant Equipment 
17,413
17,522
0
0
18,827
19,300
19,993
20,951
21,443
21,384
21,668
21,780
21,769
21,769
21,562
21,303
21,309
21,465
21,138
20,720
22,249
22,655
23,925
23,597
25,178
25,125
24,916
24,406
25,004
28,829
28,424
28,297
28,572
28,179
28,370
29,017
29,119
28,971
29,118
29,217
29,399
29,088
28,724
28,691
32,332
32,332
32,453
32,856
35,687
35,68732,85632,45332,33232,33228,69128,72429,08829,39929,21729,11828,97129,11929,01728,37028,17928,57228,29728,42428,82925,00424,40624,91625,12525,17823,59723,92522,65522,24920,72021,13821,46521,30921,30321,56221,76921,76921,78021,66821,38421,44320,95119,99319,30018,8270017,52217,413
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
71
0
0
0
30,313
0
0
0
30,062
30,06200030,313000710000000000000000000000000000000000000000
       Intangible Assets 
45
0
0
0
197
0
0
0
142
0
0
0
100
100
0
0
54
0
0
0
300
0
0
0
0
0
0
0
123
0
0
0
298
0
0
0
1,492
0
0
0
153,592
0
150,449
148,620
116,696
0
143,986
0
109,643
109,6430143,9860116,696148,620150,4490153,5920001,4920002980001230000000300000540010010000014200019700045
       Long-term Assets Other 
0
0
0
0
260
500
358
342
108
262
160
143
0
76
103
97
35
81
73
71
40
372
404
443
49
173
173
176
174
174
174
178
352
1,474
1,969
2,519
2,140
6,470
7,885
8,367
5,561
5,987
6,361
7,164
7,755
0
8,267
8,546
506
5068,5468,26707,7557,1646,3615,9875,5618,3677,8856,4702,1402,5191,9691,474352178174174174176173173494434043724071738135971037601431602621083423585002600000
> Total Liabilities 
62,716
60,344
0
0
60,721
61,800
59,558
57,705
49,409
50,350
50,254
47,642
38,700
38,625
35,497
37,313
29,485
35,770
29,184
25,927
32,953
29,911
31,858
28,279
32,618
30,425
27,794
21,205
25,740
27,626
32,486
26,360
38,478
30,978
36,326
29,616
32,027
29,308
34,007
34,914
141,843
127,946
132,561
147,086
141,987
141,987
137,637
98,666
109,968
109,96898,666137,637141,987141,987147,086132,561127,946141,84334,91434,00729,30832,02729,61636,32630,97838,47826,36032,48627,62625,74021,20527,79430,42532,61828,27931,85829,91132,95325,92729,18435,77029,48537,31335,49738,62538,70047,64250,25450,35049,40957,70559,55861,80060,7210060,34462,716
   > Total Current Liabilities 
22,895
20,305
0
0
29,179
31,100
28,709
26,697
32,578
34,180
34,514
31,451
31,000
30,888
27,909
30,231
22,939
27,364
21,821
18,934
27,206
24,839
26,628
23,721
29,397
27,449
24,984
18,613
23,569
21,571
26,656
20,616
32,739
25,357
30,267
23,192
24,967
21,977
26,147
26,589
54,057
42,229
49,680
69,150
69,275
69,275
65,826
37,272
49,183
49,18337,27265,82669,27569,27569,15049,68042,22954,05726,58926,14721,97724,96723,19230,26725,35732,73920,61626,65621,57123,56918,61324,98427,44929,39723,72126,62824,83927,20618,93421,82127,36422,93930,23127,90930,88831,00031,45134,51434,18032,57826,69728,70931,10029,1790020,30522,895
       Short-term Debt 
0
12
0
0
5,370
5,494
5,534
5,658
8,718
8,678
8,798
8,186
7,492
7,492
7,924
7,710
37
191
392
416
412
437
545
602
614
609
588
585
562
1,431
1,440
1,537
1,509
1,393
1,421
1,360
1,310
1,219
1,210
1,233
3,785
4,742
5,459
5,448
5,882
0
5,507
1,138
1,373
1,3731,1385,50705,8825,4485,4594,7423,7851,2331,2101,2191,3101,3601,4211,3931,5091,5371,4401,431562585588609614602545437412416392191377,7107,9247,4927,4928,1868,7988,6788,7185,6585,5345,4945,37000120
       Short Long Term Debt 
0
12
0
0
0
5,494
0
0
16,216
0
0
0
7,492
0
0
0
37
0
2,000
1,918
412
1,767
1,978
602
614
609
588
585
562
1,431
1,440
1,537
489
465
431
322
238
127
61
52
20,617
3,725
4,449
4,444
4,444
4,444
4,444
0
0
004,4444,4444,4444,4444,4493,72520,61752611272383224314654891,5371,4401,4315625855886096146021,9781,7674121,9182,0000370007,49200016,216005,494000120
       Accounts payable 
12,233
14,517
0
0
11,994
12,700
9,098
9,124
14,093
16,321
15,942
15,740
16,352
16,530
14,808
16,833
16,917
18,298
10,247
8,916
16,277
14,648
14,134
12,004
18,036
16,951
16,461
11,512
17,285
15,255
19,879
13,079
24,830
18,440
22,760
15,110
16,110
15,076
17,948
19,010
25,104
11,682
17,954
30,619
26,210
26,210
27,969
12,812
24,599
24,59912,81227,96926,21026,21030,61917,95411,68225,10419,01017,94815,07616,11015,11022,76018,44024,83013,07919,87915,25517,28511,51216,46116,95118,03612,00414,13414,64816,2778,91610,24718,29816,91716,83314,80816,53016,35215,74015,94216,32114,0939,1249,09812,70011,9940014,51712,233
       Other Current Liabilities 
10,355
5,776
0
0
3,639
18,400
5,481
4,312
4,313
3,750
4,510
3,627
6,964
4,045
3,385
3,866
4,064
4,350
6,068
4,744
5,614
4,843
6,772
6,299
5,820
4,912
4,862
4,662
5,261
4,424
4,876
5,439
5,811
4,875
5,497
6,236
7,325
5,682
6,989
6,346
25,128
25,765
26,227
33,043
36,764
29,414
32,312
23,307
23,065
23,06523,30732,31229,41436,76433,04326,22725,76525,1286,3466,9895,6827,3256,2365,4974,8755,8115,4394,8764,4245,2614,6624,8624,9125,8206,2996,7724,8435,6144,7446,0684,3504,0643,8663,3854,0456,9643,6274,5103,7504,3134,3125,48118,4003,639005,77610,355
   > Long-term Liabilities 
0
0
0
0
31,542
30,700
30,849
31,008
16,831
16,170
15,740
16,191
0
7,737
7,588
7,082
6,546
8,406
7,363
6,993
5,747
5,072
5,230
4,558
3,221
2,976
2,810
2,592
2,171
6,055
5,830
5,744
5,739
5,621
6,059
6,424
7,060
7,331
7,860
8,325
87,786
85,717
82,881
77,936
72,712
72,712
71,811
61,394
60,786
60,78661,39471,81172,71272,71277,93682,88185,71787,7868,3257,8607,3317,0606,4246,0595,6215,7395,7445,8306,0552,1712,5922,8102,9763,2214,5585,2305,0725,7476,9937,3638,4066,5467,0827,5887,737016,19115,74016,17016,83131,00830,84930,70031,5420000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
716
4,627
4,470
4,513
4,238
3,801
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000003,8014,2384,5134,4704,6277160000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
-12
0
0
-5,370
-5,494
-5,534
-5,658
-8,718
-8,678
-8,798
-8,186
-7,492
-7,492
-7,924
-7,710
-37
-191
-392
-416
-412
-437
-545
-602
-614
-609
-588
-585
-562
-1,431
-1,440
-1,537
3,492
3,198
3,273
3,267
3,355
3,290
3,340
3,231
529
-669
-1,957
-2,030
-2,689
6,430
528
4,717
7,449
7,4494,7175286,430-2,689-2,030-1,957-6695293,2313,3403,2903,3553,2673,2733,1983,492-1,537-1,440-1,431-562-585-588-609-614-602-545-437-412-416-392-191-37-7,710-7,924-7,492-7,492-8,186-8,798-8,678-8,718-5,658-5,534-5,494-5,37000-120
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
65,924
65,082
64,425
60,620
54,842
55,395
55,542
56,119
53,234
53,23456,11955,54255,39554,84260,62064,42565,08265,9240000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
15,073
0
0
0
10,493
0
0
0
0
0
0
7,015
0
0
0
5,608
0
0
0
3,661
0
0
0
707
0
0
0
0
0
0
0
0
421
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000421000000007070003,6610005,6080007,01500000010,49300015,0730
> Total Stockholder Equity
22,398
22,380
0
0
28,393
26,700
80,989
81,623
89,970
87,911
80,645
78,594
80,417
80,994
75,263
71,117
72,507
70,871
69,388
68,671
66,743
63,215
68,338
83,710
89,492
90,106
95,899
93,916
112,376
117,469
124,003
130,141
135,319
165,815
169,765
176,729
178,638
181,220
182,343
181,613
176,824
175,150
171,574
172,551
174,808
174,808
176,752
238,390
242,001
242,001238,390176,752174,808174,808172,551171,574175,150176,824181,613182,343181,220178,638176,729169,765165,815135,319130,141124,003117,469112,37693,91695,89990,10689,49283,71068,33863,21566,74368,67169,38870,87172,50771,11775,26380,99480,41778,59480,64587,91189,97081,62380,98926,70028,3930022,38022,398
   Common Stock
6,928
6,937
0
0
7,204
7,200
8,983
9,010
9,201
9,201
9,203
9,206
9,208
9,208
9,312
9,320
9,320
9,320
9,320
9,320
9,320
9,321
9,321
10,399
10,400
10,401
10,403
10,406
10,409
10,412
10,418
10,420
10,425
11,647
11,662
11,703
11,706
11,713
11,716
11,720
11,725
11,728
11,731
11,732
11,736
0
11,737
15,020
14,897
14,89715,02011,737011,73611,73211,73111,72811,72511,72011,71611,71311,70611,70311,66211,64710,42510,42010,41810,41210,40910,40610,40310,40110,40010,3999,3219,3219,3209,3209,3209,3209,3209,3209,3129,2089,2089,2069,2039,2019,2019,0108,9837,2007,204006,9376,928
   Retained Earnings Total Equity0000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-3,402
0
1,393
1,404
1,699
-3,520
-3,472
-3,632
0
-3,677
-3,388
-3,499
-3,477
-3,195
-3,421
-3,410
-3,579
-3,376
-3,311
-3,480
-3,785
-3,872
-3,951
-3,840
-3,509
-3,357
-3,291
-3,331
-3,696
-3,582
-3,435
-3,612
-3,453
-3,780
-3,752
-3,775
-3,585
-3,627
-3,661
-3,535
-3,050
0
-3,133
-3,270
3,324
3,324-3,270-3,1330-3,050-3,535-3,661-3,627-3,585-3,775-3,752-3,780-3,453-3,612-3,435-3,582-3,696-3,331-3,291-3,357-3,509-3,840-3,951-3,872-3,785-3,480-3,311-3,376-3,579-3,410-3,421-3,195-3,477-3,499-3,388-3,6770-3,632-3,472-3,5201,6991,4041,3930-3,4020000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
179,147
179,352
179,471
179,589
180,819
204,702
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000204,702180,819179,589179,471179,352179,1470000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
96,866
0
0
105,282
93,700
152,449
153,008
164,507
165,600
166,646
167,649
6,253
168,347
170,436
171,015
171,395
171,776
172,104
172,417
172,466
172,711
172,907
187,606
187,440
187,641
187,825
188,119
188,500
188,815
189,134
189,487
189,663
213,605
213,935
214,200
214,318
214,533
214,688
214,822
214,847
215,040
215,416
215,782
216,415
0
216,629
271,898
263,648
263,648271,898216,6290216,415215,782215,416215,040214,847214,822214,688214,533214,318214,200213,935213,605189,663189,487189,134188,815188,500188,119187,825187,641187,440187,606172,907172,711172,466172,417172,104171,776171,395171,015170,436168,3476,253167,649166,646165,600164,507153,008152,44993,700105,2820096,8660



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue144,759
Cost of Revenue-92,166
Gross Profit52,59352,593
 
Operating Income (+$)
Gross Profit52,593
Operating Expense-41,437
Operating Income11,15611,156
 
Operating Expense (+$)
Research Development13,557
Selling General Administrative18,253
Selling And Marketing Expenses9,196
Operating Expense41,43741,006
 
Net Interest Income (+$)
Interest Income588
Interest Expense-1,318
Other Finance Cost-20
Net Interest Income-710
 
Pretax Income (+$)
Operating Income11,156
Net Interest Income-710
Other Non-Operating Income Expenses0
Income Before Tax (EBT)8,56113,750
EBIT - interestExpense = 9,837
8,431
9,602
Interest Expense1,318
Earnings Before Interest and Taxes (EBIT)11,1569,880
Earnings Before Interest and Taxes (EBITDA)24,066
 
After tax Income (+$)
Income Before Tax8,561
Tax Provision-145
Net Income From Continuing Ops8,2848,416
Net Income8,284
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses133,603
Total Other Income/Expenses Net-2,594710
 

Technical Analysis of Kamada
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Kamada. The general trend of Kamada is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Kamada's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Kamada.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 5.56 < 5.57 < 5.95.

The bearish price targets are: 4.9 > 4.88 > 4.6.

Tweet this
Kamada Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Kamada. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Kamada Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Kamada. The current macd is -0.19286231.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Kamada price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Kamada. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Kamada price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Kamada Daily Moving Average Convergence/Divergence (MACD) ChartKamada Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Kamada. The current adx is 23.07.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Kamada shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Kamada Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Kamada. The current sar is 5.22.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Kamada Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Kamada. The current rsi is 36.43. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Kamada Daily Relative Strength Index (RSI) ChartKamada Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Kamada. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Kamada price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Kamada Daily Stochastic Oscillator ChartKamada Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Kamada. The current cci is -84.09290461.

Kamada Daily Commodity Channel Index (CCI) ChartKamada Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Kamada. The current cmo is -26.33602079.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Kamada Daily Chande Momentum Oscillator (CMO) ChartKamada Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Kamada. The current willr is -69.84126984.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Kamada is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Kamada Daily Williams %R ChartKamada Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Kamada.

Kamada Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Kamada. The current atr is 0.16410082.

Kamada Daily Average True Range (ATR) ChartKamada Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Kamada. The current obv is 1,404,874.

Kamada Daily On-Balance Volume (OBV) ChartKamada Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Kamada. The current mfi is 26.82.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Kamada Daily Money Flow Index (MFI) ChartKamada Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Kamada.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-03RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-15BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-27MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-18MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Kamada Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Kamada based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.426
Ma 20Greater thanMa 505.303
Ma 50Greater thanMa 1005.728
Ma 100Greater thanMa 2005.748
OpenGreater thanClose5.120
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Kamada with someone you think should read this too:
  • Are you bullish or bearish on Kamada? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Kamada? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Kamada

I send you an email if I find something interesting about Kamada.


Comments

How you think about this?

Leave a comment

Stay informed about Kamada.

Receive notifications about Kamada in your mailbox!